Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.

A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

NYU Langone researchers found that blocking a single protein in the body can trigger a form of self-destruction in lung ...

Analyzing several major pathology AI models designed to diagnose cancer, the researchers found unequal performance in ...

Pathology has long been the cornerstone of cancer diagnosis and treatment. A pathologist carefully examines an ultrathin ...

In a study published in The Journal of Clinical Investigation, University of Michigan researchers found a new protein target ...

Doctors at Main Line Health now have a new kind of robotic surgery that makes recovery quicker and easier for lung cancer patients. Traditional lung cancer surgery usually involves some pain and a ...

Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab has announced a new Phase 2 clinical study designed to evaluate ...

Lung cancer battle robotic bronchoscopy improves early diagnosis and treatment access through community lung nodule programs, reducing mortality.